|
|
|
|
Science Sparks @ ACTREC
|
 17th October 2025 |
Vol. No. 14 ; Issue No.709 |
|
|
Publications
|
|
1. Patkar S, Shah T, Vatty G, Kaderi ASA, Menon V, Baskaran D, Ostwal V, Ramaswamy A, Ramadwar M, Dikshit R, Goel M (2025). Hospital-based gallbladder cancer registry from a high-volume referral cancer centre in India: Insights into epidemiology and roadmap for enhancing cancer care. Cancer Epidemiology. 99: 102958
2. Dhingra S, Nagar A, Arora A, Singh M, Maitre P, Misra A, Pal M, Joshi A, Menon S, Garcia HA, Spiess P, Prakash G, Murthy V (2025).Radiotherapy for primary urethral carcinoma (PUC): An illustrative and narrative review. Clinical and Translational Radiation Oncology.
3. Khan z, Vira H, Ingle A(2026). Genetic monitoring of laboratory rodents using single nucleotide polymorphism . Journal of Laboratory Animal Science. 9(1):1-13.
|
|
|
|
|
Interesting Reads
|
|
Mattavelli G, Helal M, Cetkovic A, Krämer MJ, Herbert SL, Mielert K, Schlaiß T, Frank A, Riemer E, John M, Martinez Vasquez JDP, Kindl L, Swietlik JJ, Gansen BO, Krafft M, Stanojkovska E, Fischer H, Albert US, Bauer J, Delgobo M, Aintablian A, Alattar H, Lutz MB, Meissner F, Oskarsson T, Rasche L, Ramos G, Rosenwald A, Wöckel A, Riedel A. A TLR4-dependent fibroblast-monocyte axis in tumor-draining lymph nodes contributes to metastasis in triple-negative breast cancer. Immunity. 58(11):2830-2846.
|
|
|
Video of the Week
|
|
| Tumor Extracellular Vesicles and Particles Promote Metastasis and Systemic Disease |
|
| |
|
|
| |
|
|
Upcoming Events
|
| |
|
ONCOSURG 2025
|
|
November 20-22, 2025,
|
|
At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai.
|
|
|
| |
|
|
|
|
| |
|
|
| |
|
|
Do You Know?
In 2001, Results of a clinical trial showed that the drug imatinib mesylate, which targets a unique protein
|
|
|
|
Cancer News
|
| |
|
|
| |
|
|
|
The rarest element on Earth could revolutionize cancer treatment.
|
|
Sciencedaily, 11/11/2025
|
|
Scientists have unlocked new potential for astatine-211, a rare and short-lived element, as a highly precise cancer-fighting isotope. Its alpha emissions destroy tumor cells while sparing healthy tissue, making it ideal for targeted therapy...
|
|
|
|
|
|
|
|
|
2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
